X
HAE icon

Xponance’s Haemonetics HAE Stock Holding History

Xponance’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$518K Buy
6,912
+225
+3% +$14.5K ﹤0.01% 1089
2026
Q1 		$377K Buy
6,687
+893
+15% +$58.2K ﹤0.01% 1151
2025
Q4 		$464K Sell
5,794
-1,102
-16% -$74K ﹤0.01% 984
2025
Q3 		$336K Sell
6,896
-297
-4% -$18.4K ﹤0.01% 1109
2025
Q2 		$537K Sell
7,193
-39
-0.5% -$2.58K ﹤0.01% 921
2025
Q1 		$460K Sell
7,232
-14
-0.2% -$952 ﹤0.01% 960
2024
Q4 		$566K Buy
7,246
+404
+6% +$32.5K 0.01% 915
2024
Q3 		$550K Buy
6,842
+32
+0.5% +$2.58K 0.01% 910
2024
Q2 		$563K Sell
6,810
-444
-6% -$39.1K 0.01% 875
2024
Q1 		$619K Sell
7,254
-103
-1% -$8.08K 0.01% 881
2023
Q4 		$629K Buy
7,357
+93
+1% +$8.04K 0.01% 848
2023
Q3 		$651K Sell
7,264
-117
-2% -$10.4K 0.01% 791
2023
Q2 		$628K Sell
7,381
-468
-6% -$39.6K 0.01% 820
2023
Q1 		$650K Sell
7,849
-34
-0.4% -$2.75K 0.01% 818
2022
Q4 		$620K Sell
7,883
-76
-1% -$6.11K 0.01% 816
2022
Q3 		$589K Buy
7,959
+10
+0.1% +$718 0.01% 774
2022
Q2 		$518K Buy
7,949
+513
+7% +$30.4K 0.01% 843
2022
Q1 		$470K Sell
7,436
-68
-0.9% -$3.7K 0.01% 918
2021
Q4 		$398K Sell
7,504
-82
-1% -$5K 0.01% 981
2021
Q3 		$535K Sell
7,586
-416
-5% -$26.3K 0.01% 853
2021
Q2 		$533K Sell
8,002
-2,317
-22% -$164K 0.01% 899
2021
Q1 		$1.15M Buy
10,319
+204
+2% +$25.2K 0.02% 438
2020
Q4 		$1.2M Sell
10,115
-6
-0.1% -$646 0.03% 421
2020
Q3 		$883K Buy
10,121
+779
+8% +$68.1K 0.02% 446
2020
Q2 		$837K Buy
+9,342
New +$944K 0.02% 426

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Xponance's HAE Position: Q2 2026 in Review

Xponance increased its Haemonetics (HAE) stake by 3.4% in Q2 2026, buying an estimated $14.5K and bringing the position to 6,912 shares worth $518K. The position accounts for ﹤0.01% of the portfolio, ranked #1089.

Xponance first reported a position in HAE in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.2M in Q4 2020. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Xponance held 6,912 shares of Haemonetics worth $518K as of Q2 2026.
  • Xponance bought 225 Haemonetics shares in Q2 2026, an estimated $14.5K.
  • Haemonetics made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1089 holding.
  • Xponance first reported a position in Haemonetics in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Haemonetics position peaked at $1.2M in Q4 2020.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.